Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.762
Filtrar
1.
Curr Neuropharmacol ; 22(3): 420-436, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-37779399

RESUMO

The beneficial impact of physical activity on preventing and treating mental disorders has captured growing (research) interest. This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The majority of studies indicate good efficacy of physical activity in prospectively lowering the risk for the incidence of subsequent stress-related mental disorders as well as in the treatment of manifest disorders. Most evidence targets unipolar depressive disorder and, secondly, anxiety disorders. Research regarding posttraumatic stress disorder, obsessive-compulsive disorders, and somatoform disorders is promising but scarce. Physical activity seems to be useful as a stand-alone-treatment as well as in combination with other psychotherapeutic or pharmacological treatments. Multiple intertwined physiological, psychological, and social mechanisms are assumed to mediate the beneficial effects. Recommendations regarding physical activity can orientate on official guidelines but should consider the individual needs and circumstances of each subject. In summary, physical activity seems to be effective in the prevention and treatment of stressrelated mental disorders and, therefore, should be fostered in healthcare-settings. Future studies are needed to clarify partly inconsistent patterns of results and to close research gaps, e.g., concerning somatoform disorders.


Assuntos
Transtorno Depressivo , Transtornos de Estresse Pós-Traumáticos , Humanos , Transtornos de Ansiedade , Transtornos Somatoformes/terapia , Exercício Físico/psicologia
2.
Z Psychosom Med Psychother ; 69(3): 278-292, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37815582

RESUMO

Objectives: The aim of this clinical trial was to explore whether psychodynamic-interactional therapy leads to a better outcome in the treatment of somatoform pain disorders when combined with body therapy. Methods: 30 patients diagnosed with this disorder took part in outpatient group therapies with 25 sessions. In the intervention condition, sessions based on psychodynamic-interactional and body therapy took place in weekly change, while in the control condition all sessions were based on psychodynamic-interactional therapy. Data were collected with self-report measures at the beginning and end of therapy and at the 6-months follow-up. Results: Under both conditions somatic and psychological symptoms merely remained stable from the first to the third measurement time. However, patients expressed a high level of satisfaction with the relationships in the group. Conclusions: Contrary to the assumptions, the two therapy conditions did not differ in the treatment outcome. Both conditions proved successful in providing patients with supporting interpersonal experiences.


Assuntos
Terapia Psicanalítica , Transtornos Psicofisiológicos , Humanos , Dor/psicologia , Autorrelato , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia , Transtornos Somatoformes/psicologia , Resultado do Tratamento
3.
J Med Case Rep ; 17(1): 340, 2023 Aug 11.
Artigo em Inglês | MEDLINE | ID: mdl-37563729

RESUMO

BACKGROUND: There is a high prevalence of somatoform disorders and medically unexplained symptoms. When it comes to deciding whether a patient is able to work, it is essential to differentiate a somatoform disorder from a factitious disorder. The case presented demonstrates the impact on disability benefits and the subsequent psychosocial repercussions of misdiagnosing between a factitious disorder and a somatoform disorder. CASE PRESENTATION: A 42-year-old Caucasian woman worked as a 100% fiduciary accountant until the age of 32 when she was placed on medical leave due to persistent trigeminal neuralgia. Afterward, she developed total blindness, not explained by a physiological process, accompanied by distress in a crucial emotional context. We evaluated the patient for a revision of a disability income after a diagnosis of factitious disorder with severe consequences such as disability income suspension and family conflict. Our psychiatric examination concluded the diagnoses of pain disorders related to psychological factors and a dissociative neurological symptom disorder with visual disturbance. CONCLUSIONS: Blindness not explained by a physiological process may accompany trauma and psychological distress. Differentiating this pathology from factitious disorder or simulation is essential from an insurance medicine point of view, but also for its treatment.


Assuntos
Transtornos Autoinduzidos , Transtornos Somatoformes , Feminino , Humanos , Adulto , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/psicologia , Transtornos Somatoformes/terapia , Transtornos Autoinduzidos/diagnóstico , Transtornos Autoinduzidos/psicologia , Transtornos Dissociativos/diagnóstico , Transtornos Dissociativos/psicologia , Transtornos Dissociativos/terapia , Erros de Diagnóstico
4.
J Gen Intern Med ; 38(1): 195-202, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-35829874

RESUMO

The mechanism of symptom amplification, developed in the study of somatization, may be helpful in caring for patients with symptoms that, while they have a demonstrable medical basis, are nonetheless disproportionately severe and distressing. Amplified medical symptoms are marked by disproportionate physical suffering, unduly negative thoughts and concerns about them, and elevated levels of health-related anxiety. They are accompanied by extensive and sustained illness behaviors, disproportionate difficulty compartmentalizing them and circumscribing their impact, and consequent problems and dissatisfaction with their medical care. A distinction has long been made between "medically explained" and "medically unexplained" symptoms. However, a more comprehensive view of symptom phenomenology undermines this distinction and places all symptoms along a smooth continuum regardless of cause: Recent findings in cognitive neuroscience suggest that all symptoms-regardless of origin-are processed through convergent pathways. The complete conscious experience of both medically "explained" and "unexplained" symptoms is an amalgam of a viscerosomatic sensation fused with its ascribed salience and the patient's ideas, expectations, and concerns about the sensation. This emerging empirical evidence furnishes a basis for viewing persistent, disproportionately distressing symptoms of demonstrable disease along a continuum with medically unexplained symptoms. Thus, therapeutic modalities developed for somatization and medically unexplained symptoms can be helpful in the care of seriously ill medical patients with amplified symptoms. These interventions include educational groups for coping with chronic illness, cognitive therapies for dysfunctional thoughts, behavioral strategies for maladaptive illness behaviors, psychotherapy for associated emotional distress, and consultation with mental health professionals to assist the primary care physician with difficulties in medical management.


Assuntos
Sintomas Inexplicáveis , Transtornos Somatoformes , Humanos , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia , Transtornos Somatoformes/psicologia , Transtornos de Ansiedade/terapia , Ansiedade , Psicoterapia
5.
Z Psychosom Med Psychother ; 68(4): 378-396, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36511571

RESUMO

Background: In the German healthcare system benefits include inpatient and day clinic psychotherapy of trauma-related disorders, which are often provided in gender specific groups. Despite this widespread practice, the actual impact and potential outcome have been studied relatively scarcely and are still open to debate. The present study therefore examines whether the therapeutic relationships in the group vary depending on the group composition and whether this has an effect on therapy outcome. Methods: 66 patients (N = 55 women) were treated in our multimodal, day clinic groupbased treatment program and filled out symptom questionnaires (ETI, BDI-II, PHQ-15, Questionnaire on social support) at admission and discharge and the Group Questionnaire (GQ; including subscales positive bonding, positive working and negative relationships) at the end of each of the eight weeks of treatment. Patients took part in five women-only and six mixed-gender groups and underwent therapy in a closed group format, so that they began and ended therapy within the same group. All patients were diagnosed with trauma-related disorders, which included PTSD, cPTSD, depression, somatoform disorders and further mental diseases. Outcome data were examined using functional regression analysis and linear mixed models. Results: In women-only groups, positive bonding and positive working relationship were significantly higher than in mixed-gender groups. Negative relationship ratings were significantly lower in women-only groups, especially in the middle phase of treatment. However, no effect of an exclusively female group composition on treatment outcome was found, except for the higher increase of perceived social support for patients treated in women-only groups. Conclusions: Group relationships were considered more pleasant in women-only groups than in mixed-gender groups, but this had no effect on the symptom-based therapy outcome. To enhance feelings of safety and comfort, traumatized women should have the possibility to choose whether to be treated in a women-only or a mixed-gender group.


Assuntos
Transtornos de Estresse Pós-Traumáticos , Feminino , Humanos , Transtornos de Estresse Pós-Traumáticos/diagnóstico , Transtornos de Estresse Pós-Traumáticos/terapia , Psicoterapia , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia , Resultado do Tratamento , Terapia Combinada
7.
Acta Paediatr ; 111(11): 2115-2124, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36000514

RESUMO

AIM: The paper aims to show how the biopsychosocial (BPS) model can be applied as a clinical method and guide the assessment and treatment of children and adolescents with somatic symptom disorders (SSD). METHODS: Based on relevant literature and our clinical work with children and adolescents with SSD, we have developed a method to ensure a structured, interdisciplinary examination of biological, psychological and social factors, operationalising the BPS model into a clinical method. RESULTS: The BPS model renders assessment and treatment of complex conditions as a basis for evaluating phenomena not confined by diagnostic tools, but still includes all information from these tools. It requires an interdisciplinary approach, giving individual patient and caregivers a central position. A thorough medical examination is required as a starting point for assessments. Good results rest upon a shared understanding between patient, caregivers and professionals. CONCLUSIONS: 'Biopsychosocial' is often claimed as a basis for clinical work with complex cases, medical, functional and psychiatric, but scarcely with a corresponding BPS method or practice. The BPS method should guide further development of holistic, interdisciplinary health care on all levels, to assess and help children and adolescents with SSD.


Assuntos
Sintomas Inexplicáveis , Adolescente , Criança , Humanos , Modelos Biopsicossociais , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia
8.
Prog Brain Res ; 272(1): 105-123, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35667797

RESUMO

Classification of pain syndromes is quite multifaceted. However, pathogenetic classification by which chronic pain syndromes are usually divided into nociceptive, neuropathic and psychogenic, is crucial in choosing treatment tactics. In modern classifications, psychogenic pain is distinguished from nociceptive pain (associated with direct tissue injury or damage) and neuropathic pain (in which lesion can only be determined morphologically). Mental disorders play a leading role in psychogenic pain. Here, somatic/neurological disorders, if any, are of no pathogenetic significance in the dynamics of pain syndrome. There are certain algorithms (though not yet fully developed) and even guidelines for diagnosing and treating nociceptive and neuropathic pain, whereas psychogenic pain has been and still is almost out of sight for a long time. Despite its considerable prevalence, attitude towards it is still uncertain. Until now, it has no single classification, nor any strategy with regards to diagnosis, treatment and prevention.


Assuntos
Neuralgia , Humanos , Neuralgia/diagnóstico , Neuralgia/terapia , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia , Síndrome
9.
Gen Hosp Psychiatry ; 77: 11-20, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35390568

RESUMO

OBJECTIVE: For individuals with medically unexplained symptoms (MUS), cognitive behavioral therapy (CBT) is the best-evaluated treatment. This systematic review and meta-analyses identify clinical patient characteristics associated with the treatment outcome of CBT for MUS. METHODS: A systematic literature search (PubMed, PsycInfo, Web of Science) resulted in 53 eligible studies; of these 32 studies could be included in meta-analyses. Pooled correlation coefficients between predictors and treatment outcome were calculated with a random-effects model. Moderator analyses were conducted to examine differences between subgroups of MUS and different levels of methodological study quality. RESULTS: Meta-analyses demonstrated that individuals with higher symptom intensity (r = 0.38; p < 0.001), lower physical functioning (r = -0.29; p < 0.001), lower emotional and social functioning (r = -0.37; p < 0.001), more potential symptom-related incentives (r = -0.15; p = 0.001), or longer symptom duration (r = 0.10; p = 0.033) at the beginning of treatment reported less change of symptom severity until the end of therapy or higher end-of-treatment symptom severity. The pooled effect sizes did not differ between certain subgroups of MUS or between different levels of methodological quality. CONCLUSION: Our findings indicated that clinical characteristics of MUS patients are associated with treatment outcome of CBT. We discuss how the results can be used to optimize and personalize future treatments for MUS.


Assuntos
Terapia Cognitivo-Comportamental , Sintomas Inexplicáveis , Terapia Cognitivo-Comportamental/métodos , Emoções , Humanos , Transtornos Somatoformes/psicologia , Transtornos Somatoformes/terapia , Resultado do Tratamento
10.
Rev. psicol. deport ; 31(1): 17-25, mar. 2022. tab, graf
Artigo em Inglês | IBECS | ID: ibc-206012

RESUMO

The goal of this study is to investigate and test if physical exercise affects the mental health of law students. is study aim. The current study used a quantitative research approach. A questionnaire survey is carried out to collect data from respondents. Furthermore, a planned physical exercise in the experimental and control groups is used. Finally, data analysis is carried out by using a statistical tool. There was no significant difference in the level of SCL-90 between the two groups (P > 0.05). There was no significant difference in mental health between the experimental group and the control group, which met the requirements of the experiment. Through T-analysis of the data before and after the investigation, there were significant differences in somatization, obsessive-compulsive symptoms, and interpersonal sensitivity in the experimental group (P ≤ 0.05), and there were very significant differences in anxiety factors (P ≤ 0.01). Physical exercise intervention can significantly alleviate the bad mood of college students. Physical exercise is conducive to improving college students' intelligence level and reducing the learning pressure. Different sports have different effects on the psychological factors of college students; The overall impact of personal sports on psychological conditions is better than that of collective sports. Collective sports can enhance people's aggressive psychology, but individual sports individual sports cannot replace the advantages of collective sports on interpersonal relationship cannot replace the advantages of collective sports on interpersonal relationship.(AU)


Assuntos
Humanos , Adulto , Saúde Mental , Exercício Físico/psicologia , Transtornos Somatoformes/terapia , Ansiedade/terapia , Transtorno Obsessivo-Compulsivo/terapia , Estudos de Casos e Controles
11.
J Neurol Neurosurg Psychiatry ; 93(3): 280-290, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-35115389

RESUMO

Functional neurological disorder and somatic symptom disorder are complex neuropsychiatric conditions that have been linked to circuit-based dysfunction of brain networks. Neuromodulation is a novel therapeutic strategy capable of modulating relevant brain networks, making it a promising potential candidate for the treatment of these patient populations. We conducted a systematic review of Medline, Embase and PsycINFO up to 4 March 2021. Trials investigating neuromodulation devices for the treatment of functional neurological disorder or somatic symptom disorder were selected. Extracted variables included study design, demographic and clinical characteristics, psychiatric comorbidity, neurostimulation protocols, clinical outcome measures and results. 404 studies were identified with 12 meeting inclusion criteria. 221 patients were treated in the included studies with mean study sample size of 18 (4-70). Five studies were randomised clinical trials. Functional motor symptoms (six weakness, four movement disorders) were the most studied subpopulations. Transcranial magnetic stimulation (TMS) was the most frequently used device (10 studies), followed by electroconvulsive therapy (one study) and direct-current stimulation (one study). Treatment protocols varied in intended therapeutic mechanism(s): eight studies aimed to modulate underlying network dysfunction, five aimed to demonstrate movement (one also leveraged the former) and three boosted their primary mechanism with enhanced suggestion/expectation. All but one study reported positive results; however, methodological/outcome heterogeneity, mixed study quality and small sample sizes precluded quantitative meta-analysis. Neuromodulation, particularly TMS for the treatment of functional motor symptoms, shows preliminary promise in a growing line of research. Larger, sham-controlled studies are needed to further establish efficacy and better understand therapeutic mechanisms.


Assuntos
Transtorno Conversivo/terapia , Transtornos Somatoformes/terapia , Estimulação Magnética Transcraniana , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento
12.
Acta sci., Health sci ; 44: e56546, Jan. 14, 2022.
Artigo em Inglês | LILACS | ID: biblio-1367534

RESUMO

The aim of the study is to determine the psychological well-being of patients who underwent stem cell transplantation. This cross-sectional study was conducted with 100 patients. Data were collected face-to-face using an introductory information form and the Brief Symptom Inventory.When the results of the patients were examined, the interpersonal sensitivity of the sub-dimensions of the scale was found to be 5.0 ± 4.06, depression 7.60 ± 5.37, and anxiety disorder 7.90 ± 5.34. There was a significant difference between the diagnosistime of the patients and all sub-factors of the scale, except phobic anxiety. It was found that the psychological state of the patients was directly related to the time of first diagnosis. As a result, the importance of following the psychological processof the patients during the treatment process was revealed when planning nursing care.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Pacientes/psicologia , Transplante de Células-Tronco/enfermagem , Ajustamento Emocional/ética , Cuidados de Enfermagem/ética , Transtornos de Ansiedade/diagnóstico , Transtornos de Ansiedade/enfermagem , Transtornos de Ansiedade/reabilitação , Transtornos Paranoides/diagnóstico , Transtornos Paranoides/enfermagem , Transtornos Paranoides/terapia , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/enfermagem , Transtornos Psicóticos/terapia , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/enfermagem , Transtornos Somatoformes/terapia , Medula Óssea , Demografia/estatística & dados numéricos , Estudos Transversais , Depressão/diagnóstico , Depressão/enfermagem , Hostilidade , Neoplasias/diagnóstico , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/enfermagem , Transtorno Obsessivo-Compulsivo/terapia
13.
J Health Psychol ; 27(1): 3-8, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34554009

RESUMO

The American Psychiatric Association's, 2013 DSM-5 abandoned the use of the term 'medically unexplained symptoms' for non-neurological disorders. In the UK, treatments for various medical illnesses with unexplained aetiology, such as chronic fatigue syndrome, irritable bowel syndrome and fibromyalgia, continue to fall under an MUS umbrella with cognitive behavioural therapy promoted as a primary therapeutic approach. In this editorial, we comment on whether the MUS concept is a viable diagnostic term, the credibility of the cognitive-behavioural MUS treatment model, the necessity of practitioner training and the validity of evidence of effectiveness in routine practice.


Assuntos
Terapia Cognitivo-Comportamental , Síndrome de Fadiga Crônica , Sintomas Inexplicáveis , Cognição , Síndrome de Fadiga Crônica/diagnóstico , Síndrome de Fadiga Crônica/etiologia , Síndrome de Fadiga Crônica/terapia , Humanos , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia
14.
J Am Psychiatr Nurses Assoc ; 28(2): 171-180, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-32964788

RESUMO

OBJECTIVE: Patients with somatic symptom disorders (SSD) are prevalent in primary care, urgent care, and emergency rooms and present with reduced quality of life, increased disability, and suicidality . Criteria for SSD include (1) somatic symptoms that cause distress and disrupt life; (2) concurrent physical illness with thoughts and feelings that are disproportionate to the seriousness of the illness; and (3) distress which is persistent and causes suffering. The frequency of SSD in the general population is 5% to 7%; however, in primary care, it is 5% to 35% . Because patients present with anxiety, depression, and/or pain, providers are flummoxed when diagnostic findings do not match symptom intensity. The purpose of this project was to provide an intervention for patients with SSD and measure its effectiveness on their somatic symptoms. METHOD: This study provided a single-session, 30-minute psychoeducational intervention for patients to explain brain pathways for pain and the body's response to stress, including scientific benefits of exercise and healthy diet. Patients were asked questions using the motivational interviewing technique OARS (open-ended question, affirmation, reflection, summary) and were encouraged to talk about their concerns. The study used a pre- and post-intervention visual analogue scale and a self-reported Patient Health Questionnaire-15 both before and 3 weeks post-intervention. RESULTS: Measurements showed significant symptom improvement immediately after the intervention with sustained improvement 3 weeks post-intervention. CONCLUSIONS: This intervention demonstrates an effective treatment for this insidious illness, which plagues up to 35% of patients in primary care.


Assuntos
Sintomas Inexplicáveis , Manual Diagnóstico e Estatístico de Transtornos Mentais , Humanos , Dor , Atenção Primária à Saúde , Qualidade de Vida , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/epidemiologia , Transtornos Somatoformes/terapia
15.
Psychosom Med ; 84(3): 325-338, 2022 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-34524264

RESUMO

OBJECTIVE: Psychological treatments for somatic symptom disorder and functional somatic syndromes (SSD/FSS) achieve moderate effects only, potentially because of the high chronicity in these patients. Therefore, we aimed to evaluate whether early treatment, that is, treatment in populations at risk or with recent onset, improves outcome. METHODS: We conducted a systematic review and meta-analysis of (cluster-)randomized controlled trials evaluating early psychological interventions in the prevention and treatment of SSD/FSS in adults compared with inactive control conditions, standard care, or placebo. Individuals at risk for SSD/FSS, suffering from subthreshold symptoms or new onsets of SSD/FSS, or presenting with SSD/FSS for the first time were included. RESULTS: We identified 30 eligible studies, mostly examining pain-related conditions. Interventions were diverse, ranging from bibliotherapy to cognitive-behavioral therapy. We found positive effects on depression post-treatment (Hedges' g = 0.12 [95% confidence interval = 0.03-0.2], k = 5) as well as on somatic symptom severity (g = 0.25 [0.096-0.41], k = 17) and health care utilization (g = 0.31 [0.18-0.44], k = 3) at follow-up. However, because of a high risk of bias, sensitivity to corrections for meta-bias, and missing outcome data, findings should be interpreted cautiously. CONCLUSIONS: Our review shows that targeting SSD/FSS at an early stage represents a conceptual and practical challenge. Readily accessible interventions addressing transsymptomatic processes of SSD/FSS development and consolidation are highly needed. Future studies are needed to evaluate individuals with diverse symptoms, examine symptom history thoroughly, use placebo controls, and report outcomes completely to determine the efficacy of early psychological interventions for SSD/FSS.PROSPERO Registration:CRD42020140122.


Assuntos
Terapia Cognitivo-Comportamental , Sintomas Inexplicáveis , Adulto , Humanos , Intervenção Psicossocial , Transtornos Somatoformes/psicologia , Transtornos Somatoformes/terapia , Síndrome
16.
Sci Rep ; 11(1): 24282, 2021 12 20.
Artigo em Inglês | MEDLINE | ID: mdl-34930979

RESUMO

The existing treatments for somatoform dysfunction (SfD), reaction to severe stress (RSS), and adjustment disorders (AjD) are insufficiently effective and safe. Anxiolytic drug Tenoten proved effective in clinical trials (CT). The aim of this multicenter double-blind placebo-controlled randomized CT was to investigate the safety and efficacy of Tenoten in the treatment of anxiety in adults with SfD, RSS, AjD and other neurotic disorders (oNDs). 390 adult patients with SfD, RSS and AjD or oNDs with the Hospital Anxiety and Depression scale-anxiety (HADS-A) score ≥ 11 were randomized into 4 groups (n = 127 in Tenoten group 1 (4 tablets/day); n = 131 in Tenoten group 3 (8 tablets/day), n = 132 in combined Placebo group 2 + 4). The changes from baseline in the mean Hamilton Anxiety Rating Scale (HAM-A) score in groups 1 and 3 after 12 weeks were the primary outcome. The decrease of the HAM-A score from 18.81 ± 5.81 to 7.26 ± 4.63 (in group 1) and from 18.38 ± 4.3 to 6.40 ± 4.02 (in group 3) was observed post-treatment (pgroup 1/placebo = 0.0055, pgroup 3/placebo < 0.0001). Overall, 46 adverse events (28 in the Tenoten groups and 18 in the Placebo) were reported without any difference between the study groups. Tenoten performed significantly more effective than placebo in the anxiety treatment of adults with SfD, RSS, AjD and oNDs (clinicaltrials.gov NCT03036293).


Assuntos
Anticorpos/uso terapêutico , Ansiedade/tratamento farmacológico , Transtornos Neuróticos/terapia , Transtornos Somatoformes/terapia , Adolescente , Adulto , Ansiolíticos/uso terapêutico , Ansiedade/complicações , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos Neuróticos/complicações , Segurança do Paciente , Placebos , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença , Transtornos Somatoformes/complicações , Resultado do Tratamento , Adulto Jovem
17.
Z Psychosom Med Psychother ; 67(4): 416-434, 2021 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-34904551

RESUMO

Studies on the psychodynamics of Chronic Orofacial Pain Disorder Objectives: Psychodynamic factors play an important role in its emergence and development of Chronic Orofacial Pain Disorder (COP), which is also known as Chronic Primary Orofacial Pain. This factors form the basis for differentiated psychotherapy. Methods: Seven female and two male patients with COP who had visited the Dental School, University Hospital, Ludwig Maximilian University of Munich, and the dental surgery of a practising dentist over the year were included in the study. Following a detailed dental examination, a psychodynamic interview was videotaped, reconstructing the connections between the life history and the development of the illness. Psychosomatic data were assessed by 3 psychotherapists based on a consensus model with regard to symptom trigger mechanisms such as conflicts and pressure, the development of symptoms, and the personality structure. Pathogenetically, we differentiated among conversion, somatization and projection. Results: The patients had a mean age of 57 years (range: 44-67) and an average illness duration of three (1-5) years. The average age where the illness had manifested was 54 (43-64). All patients showed clear psychodynamic factors in the development and course of the illness. The symptoms developed mainly during transitional situations during the life history, predominately in midlife. During this phase, dental treatment undertaken for whatever reason could trigger the chronic symptoms, which could then be further exacerbated by further dental interventions. The mode of symptom development by equal number of patients related to a somatoform disorder, such as a somatization of affect, a conversion with conflict symbolism and a projective-hypochondriac disorder. In the remaining patients, COP was an accompanying symptom of depressive disorder or the consequence of a posttraumatic stress disorder with self-mutilating tendencies. Conclusion: The consideration of psychosomatic connections and pathogenetic differentiation is helpful for the understanding and management of COP. This diagnostic differentiation could serve as a basis for prognosis and for specific therapeutic indications. Despite numerous general researches about chronic pain syndromes, there is a lack of intervention studies which take into account the specific conditions of COP on a larger sample.


Assuntos
Dor Crônica , Doença Crônica , Dor Crônica/terapia , Dor Facial/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos da Personalidade , Transtornos Psicofisiológicos/diagnóstico , Transtornos Psicofisiológicos/terapia , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia
18.
Artigo em Inglês | MEDLINE | ID: mdl-34015195

RESUMO

OBJECTIVE: To review the published literature over the last 10 years for the efficacy of electroconvulsive therapy (ECT) in refractory somatization disorder. DATA SOURCES: A comprehensive evidence search of the published literature in the last 10 years (2010-2020) was conducted using the search terms ECT, electroconvulsive therapy, efficacy, effectiveness, use of ECT, chronic pain, somatoform disorders, somatoform pain, somatic symptom disorder, and somatization disorder. The review was limited to articles written in the English language. Databases searched included PsycInfo, MEDLINE, PubMed, Embase, and Google Scholar. A supplementary citation search was also conducted by analyzing the reference lists of identified sources. STUDY SELECTION: The initial search revealed 31 articles of potential relevance. DATA EXTRACTION: The studies were analyzed by both authors to obtain clinical information relevant to meeting the objectives of the review. DATA SYNTHESIS: Five single case studies, 1 case series, and 1 open trial focusing on the use of ECT in somatization disorder were identified for inclusion in the review. There were no controlled trials or systematic reviews, and the evidence collated was of low quality. CONCLUSIONS: This review indicates that ECT may be an effective treatment option for severe and refractory manifestations of somatization disorder. However, further research is required in the assessment of the efficacy, safety, and tolerability of ECT in somatization disorder.


Assuntos
Eletroconvulsoterapia , Humanos , Transtornos Somatoformes/terapia , Resultado do Tratamento
19.
Clin Med (Lond) ; 21(1): 13-18, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33479063

RESUMO

Medically unexplained symptoms or persistent physical symptoms are common, real and are associated with significant distress, loss of functioning and high healthcare costs. History, examination and appropriate investigations are essential to make a diagnosis. Once the diagnosis has been made, exploring the impact of the symptoms helps us to tailor our advice to patients. This paper sets out a practical approach to taking a history, assessment and stepwise management principles.


Assuntos
Sintomas Inexplicáveis , Humanos , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/terapia
20.
Clin Psychol Psychother ; 28(1): 24-38, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32539160

RESUMO

Dance movement therapy (DMT) has become an increasingly recognized and used treatment, though primarily used to target psychological and physical well-being in individuals with physical, medical or neurological illnesses. To contribute to the relative lack of literature within the field of DMT for clinical mental health disorders, using a narrative synthesis, we review the scope of recent, controlled studies of DMT in samples with different psychiatric disorders including depression, schizophrenia, autism and somatoform disorder. A systematic search of electronic databases (PubMed, Science Direct, World of Science and Clinicaltrials.gov) was conducted to identify studies examining the effects of DMT in psychiatric populations. Fifteen studies were eligible for inclusion. After reviewing the principal results of the studies, we highlight strengths and weaknesses of this treatment approach and examine the potential efficacy of using bodily movements as a tool to reduce symptoms. We conclude by placing DMT within the context of contemporary cognitive neuroscience research, drawing out implications of such an orientation for future research and discussing potential mechanisms by which DMT might reduce psychiatric symptoms. DMT has clear potential as a treatment for a range of conditions and symptoms, and thus, further research on its utility is warranted.


Assuntos
Dançaterapia , Transtornos Mentais/terapia , Saúde Mental , Transtorno Autístico/terapia , Depressão/terapia , Humanos , Esquizofrenia/terapia , Transtornos Somatoformes/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...